Abstract
Introduction
According to the World Health Organization, the definitionoffetaldeath(whichhasalsobeenadopted by the United Nations and the National Center for Health Statistics) is a "death before the complete expulsion or extraction from its mother of a product of conception, irrespective of the duration of pregnancy; the death is indicated by the fact that after such separation, the fetus does not breathe or show any other evidence of life, such as beating of theheart,pulsationoftheumbilicalcord,ordefinite movement of voluntary muscles". For the purpose of statistics,however,fetaldeathsareclassifiedaccording to gestational age, and only pregnancy losses that occur at $20 weeks' gestation are categorized as fetal deaths 1 Centers for Disease Control and Prevention, National Center for Health Statistics Web site. 1 The management of IUFD poses a dilemma. Althoughasignificantnumberofthesepatientswill spontaneously go into labour within several weeks, many do not. Moreover, after the diagnosis, the social pressures and emotional aspects of delivery are usually considerable, and the medical consequences of postponing delivery can be significant. Unfortunately, the drug most commonly used for induction of labour, oxytocin is frequently ineffective in stimulating the uterus, especially the preterm one. Within the past two decades, prostaglandins (PGs) have provided an alternative method for induction of labour in women with IUFD. 2 Misoprostol (15-deoxy-16-hydroxy-16-methyl PGE1) has been widely used for cervical ripening and labour induction in various pregnancy conditions, at different gestational ages and using different routes of administration and dosing regimens. 3 Although misoprostol is effective and inexpensive, concern has been raised regarding the widespread use of this agent as a primary or adjuvant agent for labour induction. 4 In spite of these concerns, a large body of evidence exists that shows that the use of misoprostol for labour induction ishighlyefficaciousandsafe.
5
Misoprostol is absorbed rapidly when administered orally, vaginally, rectally or intracervically. The vaginal route is advantageous because peak levels are reached slowly and sustained for long and this is associated with fewer side effects. 6, 7 The vaginal route is more effective than the oral route. [8] [9] [10] [11] The greater bioavailability of vaginal misoprostol probably explains the clinical results. Zieman et al 12 compared the absorption kinetics of misoprostol with oral versus vaginal administration in pregnant women. It was shown that the systemic bioavailability of vaginally administered misoprostol is three-times higher than that of the oral route when determined by area-under-the-curve. 13 The plasma level was sustained for up to 4 hours after vaginal administration.
The aim of this work was: To evaluate the effect of repeated vaginal administration of small doses (25 µg) of misoprostol in termination of pregnancy in cases of second and third trimester pregnancies complicated with IUFD. 
patients

Inclusion criteria
• IUFD with gestational age #20 weeks, absent spontaneous labour pain and Bishop cervical score ,5.
exclusion criteria
• Contraindications of misoprostol induction are allergy to prostaglandins, and contraindications to vaginal delivery.
Methods
• All cases were subjected to: -• History taking, general, clinical examination, ultrasound examination.
• Counseling the patient and obtaining written consent.
• The induction regimen includes application of Vagiprost 25 µg tablet in the posterior fornix of the vagina every 4 hours (up to 6 doses) after determination of Bishop Score before.
Vagiprost (Adwia, El Oubor, Egypt) is licensed in Egypt for Labor induction. The tablet was moistened with moistened with acetic acid before insertion.
13
• If the cervix is already ripe (Bishop Score $ 6) andthefirstdosedoesnotleadtoeffectivecontractions the subsequent dose could be doubled to 50 or 100 µg after 4 hours.
• If no efficient regular uterine contractions occurred after 6 doses, augmentation of uterine contractions was done by oxytocin drip, 4 hours after last misoprostol dose.
• Recording the total dose of misoprostol received and the need for surgical interference to remove the retained placenta.
• The induction trial was considered successful when induction delivery interval was less than 24 hours.
• Failure of delivery within 24 hours is considered "failed trial", but it's not indication to stop the trial ie, the trial will be completed till termination.
• Observation of patients for 24 hours after delivery.
• Any complications during induction and 24 hours after delivery were reported.
Results
• Out of 164 women third trimester pregnant women having IUFD, induction of delivery succeeded in 148 cases (90.24% 
Discussion
Studies demonstrated that the optimal intravaginal dose of misoprostol is 25 µg taken every 4 to 6 hours. Higher doses or shorter dosing intervals are associated with a higher incidence of side effects, especially hyperstimulation syndrome. 14, 15 The current investigation was conducted to assess the effectiveness of vaginal misoprostol (Vagiprost Table 1 . The mean values of parity, induction contraction interval, induction delivery interval and total needed doses of misoprostol (in micrograms) between cases in the 2nd and cases in the 3rd trimesters IUFD.
Range
Mean ± sD
P-value
notes: This table shows that there was no significant difference concerning age and parity between both studied groups. In the meantime, the induction contraction interval was significantly longer in women with 2nd trimester IUFD than the parallel value in women with 3rd trimester IUFD. Likewise, the induction delivery interval was significantly longer in women having 2nd trimester IUFD than those having 3rd trimester IUFD. In addition, the average value of total required doses of misoprostol was significantly higher in cases of 2nd trimester IUFD than that in cases of 3rd trimester IUFD. correlation between parity and induction contraction interval. In addition, inverse relatioship was instituted between parity and induction delivery interval. Furthermore, another significant negative correlation was established between parity and total required dose of misoprostol. These results agree with those of Chittacharoen et al; Caliskan et al and Yilmaz et al. 3, 13, 16 Meanwhile, that result contradicts that of Auxiliadora de Aquino and Cecatti. 17 Thepresentstudyexposedthepresenceofsignificant negative correlation between gestational age and induction contraction interval; between gestational age and induction delivery interval and between gestational age and total needed dose of misoprostol. ThesefindingsmodewiththoseofNakintu.
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In this study, the induction contraction interval in primipara and second para was significantly lower than that in nullipara. Similarly, the mean of inductioncontractionintervalmultiparaswassignificantly lower than that in nullipara. However, there was no significant difference between the induction contraction interval in primipara, second para and notes: This table shows that the induction success rate was 45% in cases of second trimester pregnancy complicated with IUFD, compared with approximately 90% in cases of third trimester pregnancy complicated with IUFD. The difference was highly significant. It is clear shows that: the need for oxytocin augmentation was significantly higher in cases 2nd trimester IUFD than that in 3rd trimester IUFD (P , 0.05).
that in third and fourth para. We found also, that the mean value of induction contraction interval in casesof2ndtrimesterIUFDwassignificantlyhigher than that in cases of 3rd trimester IUFD. This agrees with the reports of Nakintu; 18 and Bugalho and his colleagues. 19 The contemporary work shows that the induction delivery interval period in cases of 2nd and 3rd trimestersIUFDinnulliparawassignificantlyhigher than the corresponding values in women with previous history of childbirth. Approximately, 80% of patients required total misoprostol doses less than 200 µg to be delivered, and the maximum dose of 275 µg was needed by only in 10% of cases. These results differ from those of other authors. 20, 21 The total required dose of misoprostol in cases of 2nd and 3rd trimesters IUFD The success rate was 45% in cases of 2nd trimester IUFD compared with 90% in cases of the third trimester IUFD. This result agrees with that of many other authors. 22 , 23 Bugalho et al found that the success rates range from 67 to 100%.
24
The need for oxytocin augmentation was significantly higher in the 2nd trimester (90% of cases) than that in 3rd trimester cases with IUFD (55% of cases). Nyende 20 found that 20% of his cases required oxytocin augmentation to complete the induction of labour.
The necessity for surgical interference because of retained placenta was 30% in cases 2nd trimester IUFD compared with 5% in 3rd trimester IUFD. Likewise, the occurrence of side effects during induction was significantly higher in cases 2nd trimester IUFD.
As regards complications, we found them in 30% of cases of 2nd trimester pregnant women having IUFD but none in cases of third trimester. The most important side effects were fever in 10%, fever and diarrhea in 5%, nausea and vomiting in 10% and nausea, vomiting and diarrhea in 5%. All side effects happened once induction delivery interval $34 hours. Hofmeyr and Gülmezoglu speculated that the most serious complications associated with intra-vaginal misoprostol use for IUFD are premature separation of placenta, postpartum hemorrhage, and rare events suchasuterineruptureandamnioticfluidembolism. Gastrointestinal side effects: up to 35% of women will 
Induction Delivery interval
Gestational age Last but not least, we believe that vaginal administration of Vagiprost is a very effective drug for termination of pregnancy in cases of IUFD, its effects increase in direct proportion with parity and duration of pregnancy. Its use is an alternative to other treatments to terminate pregnancy in the second trimester for women with fetal death.
